Introduction {#sec1_1}
============

Optic nerve head (ONH) drusen are deposits of hyaline calcific material that are often asymptomatic and discovered incidentally on ophthalmologic examination. The overall prevalence is between 0.4 and 3.7%, although a 10-fold increase in prevalence is seen among family members \[[@B1]\]. The pattern of inheritance is believed to be autosomal dominant with incomplete penetrance; however, this has not been verified \[[@B1], [@B2]\]. The pathogenesis of ONH drusen is unknown, although it is believed to be related to dysplasia and crowding of the ONH and its blood supply. Current theories postulate that dysplasia may result in a disturbance of axonal metabolism and transport. Axons may rupture and release mitochondria into the extracellular space, which may serve as nidi for drusen formation \[[@B3]\]. Congenital abnormalities in the ONH vasculature may additionally contribute by allowing protein transudation and subsequent deposition of extracellular materials.

In a study of 27 relatives of 7 probands with bilateral ONH drusen, Antcliff and Spalton \[[@B2]\] noted the presence of an abnormal vasculature in around 50% of individuals, and additionally noted disc crowding in around 50% of individuals. However, the combination of disc crowding and an abnormal vasculature was observed in only 30% of these patients. They concluded that ONH drusen were not likely the manifestation of a single gene mutation, but rather a complex phenomenon, with inherited dysplasia of the optic disc being the primary predisposition.

Best vitelliform macular dystrophy (BVMD) is an autosomal dominant condition with onset typically in childhood and gradual progression into adulthood. The disease locus has been mapped to chromosome 11q12--13 and encodes for a calcium-activated chloride channel located in the retinal pigment epithelium (RPE) (*BEST1*; formerly *VMD2*). It is proposed that ionic homeostasis caused by dysfunction of this ion channel, bestrophin-1, results in a weakened interface between the RPE and photoreceptors \[[@B4]\]. This dysfunction could subsequently result in the accumulation of retina-derived pigment. Virtually all patients with familial BVMD demonstrate mutations in *BEST1*, with Kramer et al. \[[@B5]\] having noted a mutation in *BEST1* in 96% of patients with familial BVMD. Its diagnosis is based on electrooculography (EOG), examination of the fundus, and family history. The most meaningful finding from EOG is the Arden ratio, which is a measure of the ratio of the light peak to the dark trough. A reduced value of less than 1.5 is observed in BVMD. Choroidal neovascular membranes (CNVM) may be present in later stages of the disease.

ONH drusen have previously been reported in association with various ocular and systemic diseases. In particular, an increased frequency of optic disc drusen is observed with retinitis pigmentosa, pseudoxanthoma elasticum, and Alagille syndrome \[[@B6]\]. We describe a case series of ONH drusen in patients with BVMD (Table [1](#T1){ref-type="table"}), a phenomenon which to our knowledge has been reported on only one previous occasion thought to be an incidental finding.

Cases {#sec1_2}
=====

Case 1 {#sec2_1}
------

A 54-year-old father with a known diagnosis of BVMD confirmed by EOG done 10 years prior by an outside provider presented with his 3 children. His eye examination had been stable over several years, with a visual acuity of 20/15 to 20/20 OD and 20/70 to 20/80 eccentrically OS. His anterior segment examination was unremarkable. On fundus examination, his optic nerves appeared crowded with blurring of the disc margins. There appeared to be an increase in vasculature branching. There were focal areas of yellow subretinal deposits along the vascular arcades OU. The macula OD showed RPE changes. The macula OS had central atrophy (Fig. [1a, b](#F1){ref-type="fig"}). The periphery of both eyes demonstrated dot-blot hemorrhages consistent with his known diagnosis of moderate diabetic retinopathy. Optical coherence tomography (OCT) demonstrated stable focal areas of subretinal fluid OU and macular atrophy OS. In addition, a thick choroid with large vessels was noted OU. Fundus autofluorescence (FAF) demonstrated ONH drusen OU and mottled hypoautofluorescence in both maculas and in areas corresponding to the yellow subretinal deposits OU (Fig. [2a, b](#F2){ref-type="fig"}).

Case 2 {#sec2_2}
------

The 22-year-old son of our first patient had also been diagnosed with BVMD with a progressive course at the age of 6 years by an outside provider. He had no other past medical issues. The examination results had been stable, with vision 20/30 to 20/50 OD and 20/50 to 20/70 OS. His pupils, intraocular pressure values, and slit lamp examination results were normal OU. The fundus examination was significant for slightly elevated ONH with blurred margins OU. Both maculas demonstrated atrophic changes with signs of old regressed CNVM. He had a fibrous scar OS from the fovea toward the ONH (Fig. [1c, d](#F1){ref-type="fig"}). OCT demonstrated macular scarring with increased subretinal hyperreflectivity and stable subretinal fluid versus lucency. Previous fluorescein angiography had demonstrated staining of the macula scarring OU. FAF revealed ONH drusen OS and central foveal hypoautofluorescence OU. Initial EOG was unreliable due to artifacts; this was not pursued further due to a family history and initial appearance on examination characteristic of BVMD. The patient deferred genetic testing.

Case 3 {#sec2_3}
------

The 16-year-old daughter of the first patient had been diagnosed with BVMD at 5 years of age affecting only the left eye. She had no other medical issues. Her vision OS had been 20/40 to 20/30 until the age of 12 years, when her vitelliform lesion began to scramble. Until the time of presentation, her vision had remained stable at 20/15 to 20/20 OD but declined to 20/50 to 20/60 OS. Her anterior segment examination was normal. The fundus examination was significant for elevated ONH with blurred margins. There appeared to be an increase in retinal vasculature branching, more OS than OD. The macula OS demonstrated pigment mottling and early atrophy surrounding a central vitelliform elevation (Fig. [1e, f](#F1){ref-type="fig"}). Initial B-scan ultrasound confirmed the evidence of ONH drusen OD only (Fig. [3a](#F3){ref-type="fig"}). Subsequent FAF demonstrated ONH drusen OU (Fig. [2c, d](#F2){ref-type="fig"}). Of note, another member of family 1, a fraternal twin sister, carries the diagnosis of ONH drusen confirmed by both B-scan and FAF, although she has had no signs of BVMD to date.

Case 4 {#sec2_4}
------

A 22-year-old man with a known diagnosis of BVMD diagnosed by an outside provider presented to establish care. His other ocular history was significant for secondary glaucoma, requiring a glaucoma shunt OS. His family history was significant for BVMD in the patient\'s father, paternal grandmother, and great grandmother, although notably none of the family members were known to have ONH drusen. The patient\'s visual acuity had been stable at 20/50 to 20/60 OD and 20/80 to 20/100 OS. His pupil examination was significant for an afferent pupillary defect OS. His intraocular pressures had ranged from the low 20s to mid-10s. The slit lamp examination was unremarkable OD and OS demonstrated a superotemporal tube shut with a 3+ posterior subcapsular cataract. The fundus examination revealed ONH with blurred margins OD and an increased cup-to-disc ratio to 0.7 OS. His fundus examination revealed significant atrophic macular changes OU, with the left eye having a large arteriovenous malformation connecting to the area of atrophy thought to be secondary to old CNVM from his vitelliform lesion. There appeared to be an increase in retinal vasculature branching OD (Fig. [1g, h](#F1){ref-type="fig"}). A B-scan and FAF confirmed the presence of ONH drusen OU (Fig. [2e, f](#F2){ref-type="fig"}, [3b, c](#F3){ref-type="fig"}). OCT demonstrated hyperreflective subfoveal lesions bilaterally. Fluorescein angiography showed bilateral macular scarring staining without leakage. There was venous filling of the arteriovenous malformation connecting to macular scar but no active CNVM. The patient declined genetic testing.

Case 5 {#sec2_5}
------

A 38-year-old woman with a history of BVMD diagnosed at the age of 6 years presented for follow-up. Her family history was significant for BVMD in her father and sister. Her vision was 20/60 OU with no improvement on pinhole examination. Her anterior segment examination result was unremarkable. On fundoscopy, her optic nerves were relatively small, crowded, and with slight blurring of the nasal disc margins. Her fundus examination revealed a subfoveal fibrotic scar OD and macular RPE atrophy OS (Fig. [1i, j](#F1){ref-type="fig"}). OCT showed subfoveal hyperreflective lesions consistent with old regressed CNVM, and stable subretinal fluid OU. FAF demonstrated ONH drusen and macular hypoautofluorescence OU (Fig. [2g, h](#F2){ref-type="fig"}). A B-scan demonstrated ONH drusen OU (Fig. [3d, e](#F3){ref-type="fig"}). The patient declined genetic testing.

Discussion {#sec1_3}
==========

To our knowledge, the only previous case of ONH drusen in association with presumed BVMD was reported in 1975 by Benson et al. \[[@B7]\]. The diagnosis of BVMD was made by a clinical diagnosis of bilateral vitelliform lesions, although notably this patient did not have genetic testing or EOG. The patient was a 9-year-old child whose family history unfortunately was unknown as the patient was adopted. The authors noted that they believed the coexistence of these conditions to be coincidental.

Although a coincidental relationship between the conditions is certainly possible, we open for discussion the possibility that BVMD predisposes individuals to having ONH drusen. The role of bestrophin-1 as a protein with a transmembrane domain in the RPE is of interest, as drusen are known to form during RPE destabilization. In one theory, drusen formation begins with inflammation and subsequent loss of RPE cells. This loss in the epithelial barrier allows for retinal drusen accumulation \[[@B8]\].

ONH drusen, in association with retinitis pigmentosa and microphthalmos, have been reported in a case series of patients with dysfunction of membrane frizzled-related protein (MFRP), which, like bestrophin-1, is expressed in the RPE and contains a transmembrane domain. Won et al. \[[@B9]\] concluded that MFRP plays a wider role in eye development than previously suspected, not only functioning as a regulator of axial eye length but also having a photoreceptor maintenance role during retinal development. Due to the fact that bestrophin-1 contains a transmembrane domain in the RPE, we question if the protein plays a role in membrane stabilization, among other functions in ocular development.

Vincent et al. \[[@B10]\] described the spectrum of phenotypic characteristics of *BEST1*-related autosomal dominant vitreoretinochoroidopathy in a family with a p.V86M mutation. Autosomal dominant vitreoretinochoroidopathy is a slowly progressive vitreoretinal degeneration with significant intra-familial phenotypic variability, including optic nerve dysplasia, microcornea, a shallow anterior chamber, and iris dysgenesis. *BEST1* is proposed to have a role in normal ocular development in this condition. ONH drusen were not reported by Vincent et al. \[[@B10]\], and, likewise, we did not observe optic nerve dysplasia, microcornea, or a shallow anterior chamber in our patients. However, our patients had crowded optic nerves, and 4 of them appeared to have increased retinal vasculature branching, findings previously noted in increased frequency among patients with ONH drusen. We argue that these differences could be attributed to phenotypic variability in the *BEST1* gene. Of further interest is the theory that ONH drusen are a by-product of ONH dysplasia. This would open a discussion of the role of *BEST1* in ocular development and could potentially explain the association of BVMD with ONH drusen in our patients. Further investigation including genetic testing is needed to better understand if any correlation may exist between the two conditions. Also, of note, our patients had relatively advanced stages of Best disease, indicating a possible relationship between the presence of ONH drusen and advanced stages of Best disease.

Our case series is limited in that no genetic testing was performed, since the patients were not interested in having this test. Genetic testing could help understanding this potential association, given that both conditions could be inherited in an autosomal dominant fashion. Since some patients can have buried ONH drusen, which are difficult to identify on examination, we recommend that clinicians perform FAF imaging and ultrasound on patients with a diagnosis of BVMD to help facilitating the diagnosis of this association.

Additionally, we mentioned a member of family 1, a fraternal twin sister, who carries the diagnosis of ONH drusen but who had no signs of BVMD on her most recent examination at 16 years of age. This could weaken the argument that BVMD contributes to the formation of ONH drusen. Unfortunately, we were unable to follow this patient to monitor for early signs of BVMD, and so we are unable to accurately comment on whether or not this patient currently possesses the disease. Previous studies have shown that the age at onset and disease severity are highly variable among patients with BVMD, even among family members, and that the age at onset may be as late as the 6th decade of life \[[@B11], [@B12]\]. This patient potentially could be monitored with EOG, as previous studies have demonstrated abnormal EOG findings in light of a normal fundus examination in some heterozygous carriers \[[@B13]\]; however, EOG results are not always abnormal in patients with BVMD \[[@B14]\]. Genetic testing would be ideal to determine if the patient carries the same mutation but manifests a different phenotype or late presentation of BVMD.

It is important to be aware of this association, as ONH drusen can be present with visual field defects, anterior ischemic optic neuropathy because of crowding of the optic nerve and axon compression, and peripapillary CNVM. In addition, knowing of this association could help to avoid unnecessary neurological workup in young patients that present with visual loss and pseudo-disc edema \[[@B15]\].
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![Fundus photographs. **a**, **b** Images from a 54-year-old man (case 1) with BVMD which demonstrate elevated optic nerves with mild blurring of the margins OU and focal areas of subretinal deposits along the vascular arcades OU as well as macular atrophy OS. **c**, **d** Images from the 22-year-old son of case 1 (case 2), also with BVMD, demonstrating elevated optic nerves with mild blurring of the margins and atrophic maculas OU with signs of old regressed CNVM and a fibrous scar extending from the fovea to the ONH OS. **e**, **f** Images from the 16-year-old daughter of case 1 (case 3), demonstrating elevated optic nerves and moderate blurring of the margins with a vitelliform macular lesion OS. **g**, **h** Images from a 22-year-old man (case 4), demonstrating an elevated ONH with blurred margins and a severely glaucomatous optic nerve OS. The patient also has atrophic maculas OU with a dilated and tortuous draining vein with chorioretinal anastomosis thought to be secondary to an old CNVM from his vitelliform lesion OS. **i**, **j** Images from a 38-year-old woman (case 5), demonstrating elevated optic nerves with blurred margins OU, a subfoveal fibrotic scar OD, and macular RPE atrophy OS. BVMD, Best vitelliform macular dystrophy; ONH, optic nerve head; CNVM, choroidal neovascular membrane; RPE, retinal pigment epithelium.](cop-0009-0076-g01){#F1}

![Fundus autofluorescence photographs. **a**, **b** Images from a 54-year-old man (case 1), demonstrating ONH drusen OU and mottled hypoautofluorescence in both maculas and in areas along the vascular arcades corresponding to yellow subretinal deposits OU (see Fig. [1a, b](#F1){ref-type="fig"}). **c**, **d** Images from a 16-year-old female (case 2), demonstrating ONH drusen OU with central hypo-/hyperautofluorescence centrally OS. **e**, **f** Images from a 22-year-old man (case 4), demonstrating ONH drusen OU and mottled hypoautofluorescence in both maculas. **g**, **h** Images from a 38-year-old woman, demonstrating ONH drusen and macular hypoautofluorescence OU. ONH, optic nerve head.](cop-0009-0076-g02){#F2}

![B-scans demonstrating calcification and posterior shadowing from ONH drusen in a 16-year-old girl (**a**; case 3, OD), a 22-year-old man (**b**, **c**; case 4, OD and OS, respectively), and a 38-year-old woman (**d**, **e**; case 5, OD and OS, respectively). ONH, optic nerve head.](cop-0009-0076-g03){#F3}

###### 

Clinical history, examinations, and advanced testing of 5 reported patients with a history of BVMD and ONH drusen

  Patient; family, No.   Age, years; gender   Family history                                                                                          Visual acuity                                                    Fundoscopic examination                 Optical coherence tomography                                                                              Fundus autofluorescence                                                                       Fluorescein angiography                               Electrooculogram                          B-scan ultrasound
  ---------------------- -------------------- ------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------- --------------------------------------- --------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- ----------------------------------------------------- ----------------------------------------- ---------------------------------------------------
  1; 1                   54; M                Fraternal twin sister of patient 3 with ONH drusen confirmed by B-scan and FAF in the absence of BVMD   20/15--20/20 OD and 20/70--20/80 OS; stable for several years    See Fig. [1a, b](#F1){ref-type="fig"}   Stable focal areas of subretinal fluid OU, macular atrophy OS, thick choroid and large vessels OU         ONH drusen OU and macular hypoautofluorescence (Fig. [2a, b](#F2){ref-type="fig"})            Not performed                                         By outside provider, suggestive of BVMD   Not performed
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  2; 1                   22; M                                                                                                                        20/30--20/50 OD and 20/50--20/70 OS; stable for several years    See Fig. [1c, d](#F1){ref-type="fig"}   Macular scarring with increased subretinal hyperreflectivity and stable subretinal fluid versus lucency   ONH drusen OS and central foveal hypoautofluorescence OU (per report from outside facility)   Staining of macular scarring OU                       Unreliable due to artifacts               Not performed
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  3; 1                   16; F                                                                                                                        OD stable at 20/15--20/20, OS slowly declining to 20/50--20/60   See Fig. [1e, f](#F1){ref-type="fig"}   Not performed                                                                                             ONH drusen OU (Fig. [2c, d](#F2){ref-type="fig"})                                             Not performed                                         Not performed                             ONH drusen OD (Fig. [3a](#F1){ref-type="fig"})
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  4; 2                   22; M                Father, paternal grandmother, great grandmother with BVMD                                               20/50--20/60 OD and 20/80--20/100 OS; stable for years           See Fig. [1g, h](#F1){ref-type="fig"}   Hyperreflective subfoveal lesions OU                                                                      ONH drusen OU (Fig. [2e, f](#F2){ref-type="fig"})                                             Bilateral macular scarring staining without leakage   Not performed                             ONH drusen OU (Fig. [3b, c](#F3){ref-type="fig"})
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  5; 3                   38; F                Father and sister with BVMD                                                                             20/60 OU; stable for years                                       See Fig. [1i, j](#F1){ref-type="fig"}   Subfoveal hyperreflective lesions consistent with old regressed CNVM, and stable subretinal fluid OU      ONH drusen and macular hypoautofluorescence OU (Fig. [2g, h](#F2){ref-type="fig"})            Not performed                                         Not performed                             ONH drusen OU (Fig. [3d, e](#F3){ref-type="fig"})

BVMD, Best vitelliform macular dystrophy; ONH, optic nerve head; FAF, fundus autofluorescence; CNVM, choroidal neovascular membrane.
